Literature DB >> 11830467

A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.

Sentot Santoso1, Volker Kiefel, Ina G Richter, Ulrich J H Sachs, Abdul Rahman, Bettina Carl, Harmut Kroll.   

Abstract

This report describes a new low-frequency alloantigen, Oe(a), responsible for a case of neonatal alloimmune thrombocytopenia (NAIT). In a population study none of 600 unrelated blood donors was an Oe(a) carrier. By immunochemical studies the Oe(a) antigen could be assigned to platelet glycoprotein (GP) IIIa. Sequencing of GPIIIa complementary DNA from an Oe(a) (+) individual showed deletion of a lysine residue at position 611 (DeltaLys(611)). Analysis of 20 Oe(a) (-) and 3 Oe(a) (+) individuals showed that the DeltaLys(611) form of GPIIIa was related to the phenotype. Anti-Oe(a) reacted with the DeltaLys(611), but not with the wild-type isoforms on stable transfectants expressing GPIIIa, indicating that DeltaLys(611) directly induces the expression of Oe(a) epitopes. Under nonreducing conditions the Pro(33)DeltaLys(611) variant migrated with a slightly decreased molecular weight compared to the Pro(33)Lys(611) isoform suggesting that DeltaLys(611) has an influence on the disulfide bonds of GPIIIa. The Pro(33)DeltaLys(611) GPIIIa could undergo conformational changes and bind to fibrinogen in a similar manner as the Pro(33)Lys(611) isoform. No difference was found in the tyrosine phosphorylation of pp125(FAK), suggesting that DeltaLys(611) has no effect on integrin function. In contrast to all other low-frequency antigens, the DeltaLys(611) isoform was associated with the HPA-1b, but not with the high frequency HPA-1a allele. Comparison with GPIIIa DNA from nonhuman primates indicated that the HPA-1a allele represents the ancestral form of GPIIIa. It can be assumed that the Oe(a) form did arise as a result of a mutational event from an already mutated GPIIIa allele.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830467     DOI: 10.1182/blood.v99.4.1205

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Shannon M Pechauer; Maria L Gitter; Adam Kanack; Brian R Curtis; Jeff Reese; Vasudeva M Kamath; Janice G McFarland; Richard H Aster
Journal:  Transfusion       Date:  2011-11-09       Impact factor: 3.157

2.  Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Maria Gitter; Daniel W Bougie; Shannon Pechauer; Kathleen A Hopp; Brad Pietz; Aniko Szabo; Brian R Curtis; Janice McFarland; Richard H Aster
Journal:  Transfusion       Date:  2013-10-16       Impact factor: 3.157

3.  Establishment of a cell line panel for the detection of antibodies against human platelet antigen 4b.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Masayasu Inoue; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

4.  Detection of anti-human platelet antibodies against integrin α2β1 using cell lines.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Nobuki Matsuyama; Kazuta Yasui; Rika Ann Furuta; Yuji Hori; Shigenori Tanaka; Yasuo Fukumori; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2012-11-22       Impact factor: 3.443

5.  Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.

Authors:  Nanyan Zhang; Sentot Santoso; Richard H Aster; Brian R Curtis; Peter J Newman
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

6.  A point mutation in the EGF-4 domain of β(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor function.

Authors:  Ulrich J Sachs; Tamam Bakchoul; Olga Eva; Astrid Giptner; Gregor Bein; Richard H Aster; Maria Gitter; Julie Peterson; Sentot Santoso
Journal:  Thromb Haemost       Date:  2011-11-24       Impact factor: 5.249

7.  Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Stephanie M Balthazor; Brian R Curtis; Janice G McFarland; Richard H Aster
Journal:  Transfusion       Date:  2005-09       Impact factor: 3.157

Review 8.  Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.

Authors:  Julie A Peterson; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

9.  Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.

Authors:  Brian R Curtis; Andrea Fick; Andrew J Lochowicz; Janice G McFarland; Robert H Ball; Julie Peterson; Richard H Aster
Journal:  Transfusion       Date:  2007-11-19       Impact factor: 3.157

10.  New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Maria L Gitter; Adam Kanack; Brian Curtis; Janice McFarland; Daniel Bougie; Richard Aster
Journal:  Transfusion       Date:  2009-10-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.